Pharmaco‐Invasive Strategy: The Answer to Improving ST‐Elevation–Myocardial Infarction Care
Year: 2020
Type: editorial
Abstract: T-segment-elevation myocardial infarction (STEMI) is a leading cause of death worldwide, 1 and immediate reperfusion can be life-saving.2 Although primary percutaneous coronary intervention (PCI) is the most effective modality for achieving reperfusion in STEMI, 2,3 the benefit of primary PCI over thrombolytics on survival is time-dependent.Prior studies have showed that the survival benefit of primary PCI over thrombolytics may be negated if PCI-related delay exceeds by >60 minutes.4 Accordingly, national quality improvement initiatives during the past decade have focused on reducing delays in primary PCI, especially in patients who present directly to a PCI-capable hospital.
Authors: Amgad Mentias, Saket Girotra
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,750
OpenAlex ID: W3033675251